Published in Vaccine Weekly, October 9th, 2002
In a case-control study in children under a year old, A. Roca and colleagues, University of Barcelona, evaluated "the effect of serum antibodies on the incidence of respiratory syncytial virus (RSV) infection."
"Sera were collected from a total of 31 cases of RSV infection and paired uninfected controls matched for age and sex. Anti-RSV antibodies were assessed by a membrane fluorescent antibody test (MFAT) for immunoglobulin G (IgG) antibodies and by a neutralizing antibody test,"...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly